Galenica AG (SWX:GALE)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 4.20B -0.7% |
| Revenue (ttm) | 4.29B +6.4% |
| Net Income | 159.18M -17.2% |
| EPS | 3.19 -17.4% |
| Shares Out | 49.82M |
| PE Ratio | 26.13 |
| Forward PE | 20.84 |
| Dividend | 2.50 (3.02%) |
| Ex-Dividend Date | Apr 23, 2026 |
| Volume | 113,841 |
| Open | 84.35 |
| Previous Close | 84.35 |
| Day's Range | 83.10 - 84.35 |
| 52-Week Range | 80.30 - 103.00 |
| Beta | 0.28 |
| Analysts | Hold |
| Price Target | 87.60 (+5.42%) |
| Earnings Date | Aug 6, 2026 |
About Galenica AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and prod... [Read more]
Financial Performance
In 2025, Galenica AG's revenue was 4.15 billion, an increase of 5.48% compared to the previous year's 3.93 billion. Earnings were 181.10 million, a decrease of -1.01%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for GALE stock is "Hold." The 12-month stock price target is CHF 87.60, which is an increase of 5.42% from the latest price.
News
Galenica AG Earnings Call Transcript: Q2 2026
Sales grew 7.1% to CHF 2.136 billion in H1 2026, with adjusted EBIT up 7.1% and strong market share gains in prescription medicines. Strategic priorities in omni-channel, home care, and digitalization drove performance, and guidance for 2026 is reaffirmed.
Galenica AG Quarterly report: Q2 2026
Galenica AG has published its Q2 2026 quarterly earnings report on August 6, 2026.
Galenica AG Slides: Q2 2026
Galenica AG has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Galenica AG Earnings release: Q2 2026
Galenica AG released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Galenica AG Slides: Investor presentation
Galenica AG has posted slides in relation to its latest quarterly earnings report, which was published on August 6, 2026.
Galenica AG Earnings release: Q1 2026
Galenica AG released its Q1 2026 earnings on May 28, 2026, summarizing the period's financial results.
Galenica AG Slides: Q1 2026
Galenica AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 28, 2026.
Galenica AG Earnings Call Transcript: H2 2025
Strong sales and EBIT growth in 2025 were driven by organic expansion, acquisitions, and efficiency gains, with a positive outlook for 2026 and beyond. Strategic milestones included the Labor Team acquisition, ERP upgrades, and a focus on profitable segments.
Galenica AG Quarterly report: H2 2025
Galenica AG has published its H2 2025 quarterly earnings report on March 10, 2026.
Galenica AG Annual report: H2 2025
Galenica AG has published its H2 2025 annual report on March 10, 2026.
Galenica AG Slides: H2 2025
Galenica AG has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 10, 2026.
Galenica AG Slides: Investor presentation
Galenica AG has posted slides in relation to its latest quarterly earnings report, which was published on March 10, 2026.
Galenica AG Earnings release: Q4 2025
Galenica AG released its Q4 2025 earnings on January 22, 2026, summarizing the period's financial results.
Galenica AG Slides: Q4 2025
Galenica AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on January 22, 2026.
Galenica AG Transcript: Investor Day 2025
Transformation is driven by culture, digitalization, and staff engagement, with major investments in logistics, diagnostics, and omni-channel pharmacy services. Growth is targeted through innovation, acquisitions, and efficiency, while regulatory changes and market trends are actively managed.
Galenica AG Slides: FY 2025
Galenica AG has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 28, 2025.
Galenica AG Earnings release: Q3 2025
Galenica AG released its Q3 2025 earnings on October 23, 2025, summarizing the period's financial results.
Galenica AG Slides: Q3 2025
Galenica AG has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 23, 2025.